LEXINGTON, Mass.--(BUSINESS WIRE)--
Cubist Pharmaceuticals, Inc. (CBST) today announced that Steve Gilman, Cubist’s Executive Vice President and Chief Scientific Officer, will present at the Goldman Sachs U.S. Emerging SMID Cap Growth Conference on Thursday, November 14, to discuss the company’s business activities, financial outlook, and recent news.
The presentation will be held at the Marriott Marquis hotel in New York City on Thursday, November 14, 2013 at 2:00 p.m. Eastern Time.
This audio-only presentation will be accessible live through Cubist’s website at www.cubist.com in the Investor Relations Conference Calendar section and will remain available there for a period of 30 days after the presentations.
Cubist Pharmaceuticals, Inc. is a biopharmaceutical company focused on the research, development, and commercialization of pharmaceutical products that address significant unmet medical needs in the acute care environment. Cubist is headquartered in Lexington, Mass. Additional information can be found at Cubist’s website.
- Health Care Industry